Our Story

The 138-year-old Ayurvedic company, promoted by the Burman family, started operations in 1884 as an Ayurvedic medicines company. From its humble beginnings in the bylanes of Calcutta, Dabur India Ltd has come a long way today to become a transnational consumer goods company with the largest herbal and natural product portfolio in the world. Dabur has successfully transformed itself from being a family-run business to become a professionally managed enterprise. What sets Dabur apart is its ability to marry traditional knowledge of Ayurveda with modern-day Science to roll out efficacious products that are tailored to suit the specific needs of consumers across the globe. As a Promoter-owned but Professionally managed Company, Dabur has always set new standards in Corporate Governance & Innovation.


Birth of Dabur

Dr. S. K. Burman launches his mission to make health care products in Calcutta


Setting up a manufacturing plant

With growing popularity of Dabur products, Dr. Burman expands his operations by setting up a manufacturing plant for mass production of formulations

Early 1900s

Ayurvedic medicines

Dabur enters the specialised area of nature-based Ayurvedic medicines , for which standardised drugs are not available in the market.


Establishment of research laboratories

The need to develop scientific processes and quality checks for mass production of traditional Ayurvedic medicines leads to establishment of research laboratories.


Expands further

Dabur expands further with new manufacturing units at Narendrapur and Daburgram. The distribution of Dabur products spreads to Bihar and the North-East.


Dabur India (Dr. S.K. Burman) Pvt. Ltd.

Dabur becomes a full-fledged company - Dabur India (Dr. S. K. Burman) Pvt. Ltd.


Shift to Delhi

Dabur's operations shift to Delhi. A new manufacturing plant is set up in temporary premises in Faridabad on the outskirts of Delhi.


Sahibabad factory / Dabur Research & Development Centre (DRDC)

Commercial production starts in the new Sahibabad factory of Dabur, one of the largest and best equipped production facilities for Ayurvedic medicines. Launch of full-fledged research operations in pioneering areas of health care with establishment of the Dabur Research & Development Centre (DRDC).


Public Limited Company

Dabur becomes a Public Limited Company. Dabur India Ltd. comes into being after reverse merger with Vidogum Limited.


Joint venture with Agrolimen of Spain

Beginning a new chapter of strategic partnerships with international businesses, Dabur enters into a joint venture with Agrolimen of Spain. This new venture is to manufacture and market confectionery items in India.


Cancer treatment

Dabur enters the specialised health care area of cancer treatment with its oncology formulation plant at Baddi in Himachal Pradesh.


Public issue

Dabur India Ltd. raises its first public issue. Due to market confidence in the Company, shares issued at a high premium are oversubscribed 21 times.


Joint Ventures

Extending its global partnerships, Dabur enters into a Joint Venture (JV) with Osem of Israel for food and Bongrain of France for Cheese & other dairy products.


3 separate divisions

For better operation and management, 3 separate divisions are created according to their product mix - Health Care, Products Division, Family Product Division & Dabur Ayurvedic Specialities Limited.


Foods Division / Project STARS

Dabur enters full-scale in the nascent processed foods market with creation of a Foods Division. Project STARS (Strive to Achieve Record Successes) is initiated to give a jump-start to the Company and accelerate its growth performance.


Professionals to manage the Company

With changing demands of business and to inculcate a spirit of corporate governance, the Burman family inducts professional to manage the company. For the first time in the history of Dabur, a non family professional CEO sits at the helm of the company.


Dabur India Ltd’s turnover crosses the Rs 1,000 Crore mark

Dabur establishes its market leadership status with a turnover of Rs.1,000 crores. From a small beginning and upholding the values of its founder, Dabur now enters the august league of large corporate businesses.


Dabur demerges Pharma Business

Dabur India approved the demerger of its pharmaceuticals business from the FMCG business into a separate company as part of plans to provide greater focus to both the businesses.


Dabur aquires Balsara

As part of its inorganic growth strategy, Dabur India acquires Balsara's Hygiene and Home products businesses, a leading provider of Oral Care and Household Care products in the Indian Market, in a INR 143 Crore all cash deal.


Dabur announces Bonus after 12 years

Dabur India announces issue of 1:1 bonus share to its shareholders (i.e. one share for every one share held.)


Dabur crosses $2bn market Cap, adopts US GAAP

Dabur India crosses the $2 billion mark in market Capitalisation. The company also adopted US GAAP in the line with the commitment to follow Global Best Practices and adopt highest standards of transparency and governance.


Approves FCCB/GDR/ADR up to $200 million

Moving forward on the inorganic growth path Dabur India decides to raise upto $200 million from the international market through bonds, FCCBs, GDR, ADR, QIPs or any other securities.


Celebrating 10 years of Real

Dabur Foods unveils the new packaging and design for Real on the occasion of 10 years completion of the brand. The new defined modern look depicts the natural goodness of the juice from freshly plucked fruits.


Foray into organised retail

Dabur India announces its foray into the organised retail business through a wholly-owned subsidiary, H&B Stores Limited. Dabur goes on to further invest INR 140 Crores by 2010 to establish its presence in the retail market in India with a chain of stores on the Health & Beauty format.


Dabur Foods Merged With Dabur India

Dabur India decides to merge its wholly owned subsidiary Dabur Foods Limited with itself to exact synergies and unlock operational efficiencies.


Acquires Fem Care Pharma

Dabur India acquires Fem Care Pharma, a leading player in the women skin care market. Besides an entry into the high growth skin care market with an established brand named Fem, this transaction also offers Dabur a strong platform to enter newer product categories and markets.


Dabur Red Paste joins 'Billion Rupee Brand' club

Dabur Red Paste becomes Dabur's 9th billion rupee brand by crossing the billion rupee turnover mark within 5 years of its launch.


Dabur makes its first overseas acquisition

Dabur makes its first overseas acquisitions by buying Hobi Kozmetik Group, a leading personal care products company in Turkey, for $69 Million. This is followed in succession by the acquisition of 100% equity in Namaste Laboratories LLC of the US for $100 Million.


Dabur enters professional skin care market

Dabur enters professional skin care market with the launch of Oxylife Professional Facial Kit, created exclusively for professional use. The range is further expanded with the launch of facials and a body bleach under the brand Fem.


Dabur India acquires 30-Plus from Ajanta Pharma

Dabur India Limited acquires Ajanta Pharma's over-the-counter brand '30-Plus'


Dabur crosses Billion-Dollar Turnover Mark

Dabur India Ltd. surpasses the billion-dollar turnover mark during the 2011-12 fiscal to end the year on a high note with net sales of INR 5283.17 Crores.


Market Capitalisation crosses the $5-Billion mark.


Brand Real, Vatika and Amla cross the Rs. 1,000-Crore turnover mark.


Dabur Gulabari and Dabur Lal Dant Manjan clock a turnover of Rs. 100 Crore each.


Acquires Company in South Africa


Mohit Malhotra takes charge as new Global CEO


Rolls out over 60 new products within 3 months


Market Cap crosses Rs 1,00,000 Crore


Dabur Red Paste clocks turnover of Rs 1,000 crore


Dabur Revenue crosses Rs 10,000 crore